Crohn's DiseaseSymptoms, Doctors, Treatments, Advances & More
Crohn's Disease Overview
Learn About Crohn's Disease
The Regents Of The University Of California
Berkeley Limketkai is a Gastroenterologist practicing medicine in Los Angeles, California. Dr. Limketkai is rated as an Elite provider by MediFind in the treatment of Crohn's Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Viral Gastroenteritis, Crohn's Disease, Colitis, Small Bowel Resection, and Colonoscopy.
Cleveland Clinic Main Campus
Miguel Regueiro is a Gastroenterologist practicing medicine in Cleveland, Ohio. Dr. Regueiro is rated as an Elite provider by MediFind in the treatment of Crohn's Disease. He is also highly rated in 16 other conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Ileostomy, and Colonoscopy. Dr. Regueiro is board certified in American Board Of Internal Medicine, 1997.
Stephen Hanauer is a Gastroenterologist practicing medicine in Chicago, Illinois. He has been practicing medicine for over 49 years. Dr. Hanauer is rated as an Elite provider by MediFind in the treatment of Crohn's Disease. He is also highly rated in 8 other conditions, according to our data. His clinical expertise encompasses Crohn's Disease, Viral Gastroenteritis, Ulcerative Colitis, Colonoscopy, and Endoscopy. Dr. Hanauer is board certified in American Board Of Internal Medicine - Gastroenterology (Certified).
Summary: The study is an extension of two parent studies (MLN0002-3024 \[NCT04779307\] and MLN0002-3025 \[NCT04779320\]). Participants must have participated in one of the previous studies. The purpose of this study is to collect the long-term safety of vedolizumab in children with UC or CD.
Summary: This study is a randomized controlled clinical trial evaluating whether two therapeutic dietary approaches - a ketogenic diet and a carnivore (lion) diet - can improve quality of life, reduce symptoms, and influence measures of disease activity in adults with inflammatory bowel disease \[ulcerative colitis and Crohn's disease\] (IBD) or rheumatoid arthritis (RA). Participants will be randomized in...

